Paper · 36763142
Chromosomal radiosensitivity of human breast carcinoma cells and blood lymphocytes following photon and proton exposures.
Kowalska A and 3 others. Radiat Environ Biophys, 2023. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Chromosomal radiosensitivity of human breast carcinoma cells and blood lymphocytes following photon and proton exposures. Papers, record 36763142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36763142
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chromosomal radiosensitivity of human breast carcinoma cells and blood lymphocytes following photon and proton exposures.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protons | Major topic |
| Breast Neoplasms | Major topic |
| Humans | |
| Female | |
| Dose-Response Relationship, Radiation | |
| Chromosomes | |
| Radiation Tolerance | |
| Chromosome Aberrations | |
| Lymphocytes |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21,778,573 | Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. | Breast Dis | 2010 | https://conductscience.org/library/papers/21778573 | PubMed |
| 2 | 11,242,102 | DNA double-strand breaks: signaling, repair and the cancer connection. | Nat Genet | 2001 | https://conductscience.org/library/papers/11242102 | PubMed |
| 3 | 26,539,409 | Biological Effectiveness of Accelerated Protons for Chromosome Exchanges. | Front Oncol | 2015 | https://conductscience.org/library/papers/26539409 | PubMed |
| 4 | 24,389,430 | Therapy-resistant cancer stem cells have differing sensitivity to photon versus proton beam radiation. | J Thorac Oncol | 2013 | https://conductscience.org/library/papers/24389430 | PubMed |
| 5 | 30,656,467 | Production and distribution of chromosome aberrations in human lymphocytes by particle beams with different LET. | Radiat Environ Biophys | 2019 | https://conductscience.org/library/papers/30656467 | PubMed |
| 6 | 31,754,773 | Modeling of chromosome aberration response functions induced by particle beams with different LET. | Radiat Environ Biophys | 2020 | https://conductscience.org/library/papers/31754773 | PubMed |
| 7 | 11,044,355 | Molecular cytogenetic analysis of breast cancer cell lines. | Br J Cancer | 2000 | https://conductscience.org/library/papers/11044355 | PubMed |
| 8 | 19,582,160 | Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. | PLoS One | 2009 | https://conductscience.org/library/papers/19582160 | PubMed |
| 9 | 2,390,488 | Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma. | Br J Cancer | 1990 | https://conductscience.org/library/papers/2390488 | PubMed |
| 10 | 26,278,043 | Effect of proton and gamma irradiation on human lung carcinoma cells: Gene expression, cell cycle, cell death, epithelial-mesenchymal transition and cancer-stem cell trait as biological end points. | Mutat Res | 2015 | https://conductscience.org/library/papers/26278043 | PubMed |
1 to 10 of 22
See all 22 referencesCited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,869,074 | Role of Different Enzymes in H2O2 Neutralization and Cellular Radioresistance, Estimated by Mathematical Modeling. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40869074 | PubMed |
| 40,691,434 | Radiobiological characterisation of a 28 MeV proton beam delivered by the MC-40 cyclotron. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/40691434 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| CSH2 | 1,443 | PubTator's text mining | https://conductscience.org/library/genes/1443 | NCBI Gene |
| ERBB2 | 2,064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| PCYT1B | 9,468 | PubTator's text mining | https://conductscience.org/library/genes/9468 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36763142
GET https://conductscience.org/api/papers/v1/36763142/references?page=2